P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,140.00
+20.00 (0.94%)
Last updated: Apr 21, 2025
-25.44%
Market Cap 63.68B
Revenue (ttm) 17.85B
Net Income (ttm) 5.82B
Shares Out 28.88M
EPS (ttm) 200.32
PE Ratio 11.01
Forward PE n/a
Dividend 40.00 (1.83%)
Ex-Dividend Date Dec 27, 2024
Volume 10,144
Average Volume 39,759
Open 2,135.00
Previous Close 2,120.00
Day's Range 2,120.00 - 2,140.00
52-Week Range 1,907.00 - 3,530.00
Beta 0.68
RSI 58.16
Earnings Date May 15, 2025

About P&K Skin Research Center

P&K Skin Research Center Co., Ltd. engages in the evaluation and research of dermatological products in South Korea. It provides scientific information and technical support services for cosmetic raw material development, functional cosmetics, and human application testing of quasi-drugs. The company performs human application, safety, efficacy, cosmeceuticals, health food, sensory, and in vitro clinical tests. It also manufactures and sells raw pharmaceutical and cosmetic materials, and raw materials for health foods. The company was founded i... [Read more]

Industry Commercial Physical and Biological Research
Founded 2010
Employees 93
Stock Exchange KOSDAQ
Ticker Symbol 347740
Full Company Profile

Financial Performance

In 2024, P&K Skin Research Center's revenue was 17.85 billion, an increase of 20.24% compared to the previous year's 14.84 billion. Earnings were 5.82 billion, an increase of 20.84%.

Financial Statements

News

There is no news available yet.